Stocks to sell

One of the big slogans favored by CNBC pundit Jim Cramer is, “There’s always a bull market somewhere.” I believe that’s true. But I think there’s also always a bear market somewhere. That’s because, even during good times, companies are always being hurt by new technologies, tough competition, and/or weak products. Additionally, there are always stocks whose

In recent months, Chinese electric-vehicle maker Nio’s deliveries and automotive revenues (NYSE:NIO) have been dropping sharply amid intensified competition from Tesla (NASDAQ:TSLA) and other automakers. Moreover, Nio lacks a significant competitive advantage, and the company’s new smartphone could hurt the automaker more than help it. Given these points, I advise investors not to buy or

In rough markets it’s important to keep and eye out for overbought stocks. Finding the right timing to buy and sell stocks will always be a sought-after skill by any investor searching for that holy grail. While I do believe that there isn’t one, I firmly believe that overbought stocks still provide signs of when

When Berkshire Hathaway (NYSE:BRK-A, NYSE:BRK-B) CEO Warren Buffett loads up on a stock, you might be tempted to do what he does. That’s understandable, as Buffett is a legendary investor. However, there’s a red flag with Snowflake (NYSE:SNOW) that prospective shareholders must consider, so don’t over-leverage yourself on SNOW stock. Snowflake is a cloud computing company

Trick or treat? It’s a pretty innocent question that greets many people every Halloweem. Most people asking that question can rest assured that they will receive candy. For stock investors, it isn’t that simple. Unfortunately, there are some spooky stocks looking to haunt your portfolio. Some stocks look very promising only to crash and burn

Investors are clearly skeptical about Ryan Cohen’s ability to save GameStop (NYSE:GME). The stock has seen its share of pops, and a big one on news that Ryan Cohen would be stepping in as the company’s CEO. Yet since this announcement, GME stock has since dropped 23% over the last month, suggesting doubts about Cohen’s

With market uncertainty being the name of the game, investors may want to red flag the most volatile stocks to avoid. Usually, securities that show greater-than-average mobility – whether to the downside or up – are speculative, growth-oriented ventures. That might work well during a decisively bullish market cycle. However, when faced with uncertainty, such

Even as the end of 2023 is still months away, now may be the time to figure out which stocks to sell ahead of 2024. All bets are off whether stocks can end the year on a high note. Issues like inflation, interest rates, and the risk of a recession continue to drive volatility among

Until recently Johnson & Johnson (NYSE:JNJ) stock was the most conservative investment you could make in the drugs space. It still is, but that’s no longer a compliment. There’s a lot more risk in it since it spun off its consumer business as Kenvue (NYSE:KVUE) on August 23. Since then JNJ stock is down 5%,

Turnaround stocks can be appealing if you’re a value investor. But you have to know the right moment to exit by spotting high-flying stocks to avoid. This has been a challenging 2023 with more losers than winners on the market. Between the cost of living crisis and the uncertain macroeconomic environment, challenges are plentiful. But

Last Monday, a landmark U.S. trial against Alphabet’s Google (NASDAQ:GOOG, NASDAQ:GOOGL) began, and the case represents one of the first antitrust cases embarked upon by the U.S. Department of Justice against a large technology company in years. What does that have to do with MSFT stock? Now, core to the Justice Department’s case is how “distribution agreements”

October is renowned for its potential to unsettle investors with significant market drops, a trend that continues from the previous month. Indeed, while certain stocks have shown an ability to weather volatility, some falling stocks are down and could still see greater declines. Here are three such stocks that have been down significantly recently and

Pfizer (NYSE:PFE) stock steadily declined since the start of 2022. Many investors are staying away, but some may be wondering whether there’s merit in making PFE stock a bottom-fisher’s buy. Among healthcare stocks, this pharmaceutical giant is seemingly a bargain. Shares currently trade for just 10 times forward earnings. The stock also sports a very

After AMC (NYSE:AMC) announced on Sept. 26 that it would distribute Taylor Swift’s movie globally and over $100 million of advance tickets were purchased for the film, AMC stock soared 25%. Given that impressive rally, I believe that huge, record-breaking profits for AMC on the film are already baked into the stock. Moreover, the shares

In the financial market’s AI race, investors are focusing on specific stocks. Palantir (NYSE:PLTR) has gained significant attention recently, with its stock more than doubling year-to-date, outperforming many other AI-related companies. For growth investors, the key question is whether PLTR stock is a worthwhile buy at its current levels or if its rally is mostly

Over the past year, Mullen Automotive’s (NASDAQ:MULN) stock has been a rollercoaster ride, with wild price swings between 10 cents and $5. The incredible volatility has likely minted some hugely profitable trades for lucky speculators. However, for most investors, I suggest avoiding this battleground stock altogether. Despite intriguing long-term plans, Mullen’s historical price performance and

A lot of investors are interested in QuantumScape (NYSE:QS) as a long-term wager on solid-state EV battery technology. However, there are plenty of traders interested in QS stock for another reason. That would be QS’s potential to experience another turbo-charged rally. Such rallies have happened twice this year. Who’s to say a third one can’t

The healthcare industry has historically provided significant returns to investors. And, it is currently boasting a compounding annual growth rate prediction of 10.4% until 2027. Despite having many extremely profitable companies that see a surge in stock price, there are also many healthcare stocks that plummet. This is because many healthcare companies rely on trials

The Dow 30 is a select group of stocks representing prominent companies in a variety of industries and sectors. A common characteristic of Dow stocks is their status as blue-chip stocks. Since blue-chip stocks are known for their stability, Dow stocks wouldn’t normally be on a list of stocks to sell. However, many of the